Lens Dose-Response Prediction Modeling and Cataract Incidence in Patients With Retinoblastoma After Lens-Sparing or Whole-Eye Radiation Therapy

Autor: Eric L. Chang, A. Linn Murphree, Steven Nguyen, Jesse L. Berry, Arthur J. Olch, Vanessa Salinas, Julian Sison, Jonathan W. Kim, Kenneth Wong, Marjorie T. Jones
Rok vydání: 2019
Předmět:
Male
Cancer Research
genetic structures
medicine.medical_treatment
Kaplan-Meier Estimate
Eye
030218 nuclear medicine & medical imaging
0302 clinical medicine
Medicine
Radiation
medicine.diagnostic_test
Incidence
Incidence (epidemiology)
Retinoblastoma
Radiotherapy Dosage
Progression-Free Survival
Oncology
Eye examination
Child
Preschool

030220 oncology & carcinogenesis
Female
medicine.medical_specialty
Retinal Neoplasms
Enucleation
Cataract
Article
03 medical and health sciences
Cataracts
Ophthalmology
Lens
Crystalline

Humans
Radiology
Nuclear Medicine and imaging

Progression-free survival
Proportional Hazards Models
Retrospective Studies
business.industry
Proportional hazards model
Infant
Dose-Response Relationship
Radiation

Retrospective cohort study
medicine.disease
eye diseases
Radiation therapy
Logistic Models
Radiotherapy
Intensity-Modulated

sense organs
Tomography
X-Ray Computed

business
Organ Sparing Treatments
Follow-Up Studies
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 103:1143-1150
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2018.12.004
Popis: PURPOSE: We retrospectively assessed the incidence of cataracts in patients with retinoblastoma (Rb) treated with either lens-sparing radiation therapy (LSRT) or whole-eye radiation therapy (WERT). A secondary aim of this study was to model the dose-response risk of cataract. METHODS AND MATERIALS: We reviewed 65 patients with Rb treated with radiation therapy (RT) at Children’s Hospital, Los Angeles from 1997 to 2015. Eyes that were enucleated before RT or lacked follow-up eye examinations were excluded. All patients underwent computed tomography simulation, and mean lens dose data were collected. Follow-up ophthalmologic examinations and intraocular lens implant history were reviewed for cataracts. The primary event-free survival (EFS) outcome was cataract development. Eyes without cataracts were censored on the last date of eye examination or post-RT enucleation, if applicable. Kaplan-Meier estimates were used to compare EFS outcomes, and dose response was projected with Cox regression and logistic regression models. RESULTS: Sixty-one patients (94 eyes) were analyzed with a median follow-up of 51.8 months. For eyes treated with WERT, cataracts developed in 71.7% versus 35.3% for LSRT. Median EFS for WERT and LSRT were 20.8 and 67.9 months, respectively. Compared with WERT, a significant EFS benefit was demonstrated for LSRT (P
Databáze: OpenAIRE